RESEARCH TRIANGLE PARK, N.C., March 6 /PRNewswire/ -- InnerPulse, Inc., a privately held company with a disruptive technology for the treatment of abnormal heart rhythms, announced the appointment of Elsa Abruzzo to the newly formed position of Vice-President of Regulatory and Quality Affairs. Ms. Abruzzo has more than 18 years of experience in the medical device industry including cardiac devices, such as heart valves, neurovascular embolic devices, and biomaterials.
Ms. Abruzzo, 40, most recently served as Vice-President Regulatory and Clinical Affairs with AtriCure, Inc., a manufacturer of cardiac ablation devices. Prior to that Elsa was with Percutaneous Valve Technologies, Inc. (PVT) where she served as head of regulatory and clinical affairs for a breakthrough percutaneous aortic valve technology. Prior to PVT, Elsa spent 10 years with CryoLife, Inc. (biomaterials, tissue heart valves and vascular grafts) and Cordis Johnson and Johnson (vascular devices), all in regulatory and quality affairs.
"We are delighted to have someone with Elsa's extensive experience join our executive team at this important juncture of the Company's evolution. She will have a key leadership role as we initiate our clinical studies and move closer to gaining regulatory approval of our novel defibrillator technology. Her experience in leading several technologies successfully through the regulatory approval process over the past 18 years will provide great value as the Company begins our clinical trials," said InnerPulse President and Chief Executive Officer Daniel A. Pelak.
Elsa is a graduate of the University of Miami with a degree in Industrial and Manufacturing Engineering.
About InnerPulse, Inc.
Founded in 2003, InnerPulse is a privately held, early-stage company
pioneering a novel technology for those patients who have cardiac rhythm
disorders. More information is available at http://www.inner-pulse.com.
Contact: Benny Ward, V.P. & C.F.O Len Hall (media)
InnerPulse, Inc. Allen & Caron Inc
919 287 4111 949 474 4300
|SOURCE InnerPulse, Inc.|
Copyright©2008 PR Newswire.
All rights reserved